Fluorescent peptide nanoparticles to detect amyloid-beta aggregation in cerebrospinal fluid and serum for Alzheimer’s disease diagnosis and progression monitoring
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Protein-based nanoparticles provide benefits including simple synthesis, high binding capacity for different medications, non-toxicity, non-immunogenicity, biocompatibility, biodegradability, and plasma half-life.
“Protein-based nanoparticles provide a number of benefits, including simple synthesis, a high binding capacity for different medications, non-toxicity, non-immunogenicity, biocompatibility, biodegradability, and plasma half-life.56–58”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [57]
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569 · see citing works
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · see citing works
Self-assembling organic nanotubes based on a cyclic peptide architecture
Ghadiri, M. R., Granja, J. R., Milligan, R. A., McRee, D. E., & Bernstein, N. K. (1993) · Nature · doi:10.1038/366324a0 · Cited by 1,747 · see citing works
Amyloid β Protein and Alzheimer’s Disease: When Computer Simulations Complement Experimental Studies
Nasica-Labouze, J., Nguyen, P. H., Sterpone, F., Berthoumieu, O., Buchete, N., Côté, S., Simone, A. D., Doig, A. J., Faller, P., Garcı́a, A. E., et al. (2015) · Chemical Reviews · doi:10.1021/cr500638n · Cited by 583 · see citing works
Half a century of amyloids: past, present and future
Ke, P. C., Zhou, R., Serpell, L. C., Riek, R., Knowles, T. P. J., Lashuel, H. A., Gazit, E., Hamley, I. W., Davis, T. P., Fändrich, M., et al. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00199a · Cited by 567 · see citing works
Using Graphene Oxide High Near‐Infrared Absorbance for Photothermal Treatment of Alzheimer's Disease
Li, M., Yang, X., Ren, J., Qu, K., & Qu, X. (2012) · Advanced Materials · doi:10.1002/adma.201104864 · Cited by 535 · see citing works
Localized Surface Plasmon Resonance Biosensors
Zhao, J., Zhang, X., Yonzon, C. R., Haes, A. J., & Duyne, R. P. V. (2006) · Nanomedicine · doi:10.2217/17435889.1.2.219 · Cited by 509 · see citing works
Identifying and validating biomarkers for Alzheimer's disease
Humpel, C. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.09.007 · Cited by 484 · see citing works
Fan, Z., Sun, L., Huang, Y., Wang, Y., & Zhang, M. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.312 · Cited by 369 · see citing works
Self-citationA Molecular Model of Alzheimer Amyloid β-Peptide Fibril Formation
Tjernberg, L. O., Callaway, D. J. E., Tjernberg, A., Hahne, S., Lilliehöök, C., Terenius, L. Y., Thyberg, J., & Nordstedt, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12619 · Cited by 360 · see citing works
Mulder, C., Verwey, N. A., van der Flier, W. M., Bouwman, F. H., Kok, A., van Elk, E. J., Scheltens, P., & Blankenstein, M. A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.130518 · Cited by 332 · see citing works
Ou, Z., Deng, L., Lu, Z., Wu, F., Liu, W., Huang, D., & Peng, Y. (2020) · Nutrition & Diabetes · doi:10.1038/s41387-020-0115-8 · Cited by 328 · see citing works
The future of blood‐based biomarkers for Alzheimer's disease
Henriksen, K., O’Bryant, S. E., Hampel, H. J., Trojanowski, J. Q., Montine, T. J., Jeromin, A., Blennow, K., Lönneborg, A., Wyss‐Coray, T., Soares, H. D., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.013 · Cited by 312 · see citing works
Strategies for transporting nanoparticles across the blood–brain barrier
Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W. (2016) · Biomaterials Science · doi:10.1039/c5bm00383k · Cited by 308 · see citing works
Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues
Brambilla, D., Droumaguet, B. L., Nicolas, J., Hashemi, S. H., Wu, L., Moghimi, S. M., Couvreur, P., & Andrieux, K. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.03.008 · Cited by 293 · see citing works
Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging
Wadghiri, Y. Z., Sigurdsson, E. M., Sadowski, M. J., Elliott, J. I., Li, Y., Scholtzova, H., Tang, C. Y., Aguinaldo, G., Pappolla, M. A., Duff, K., et al. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10529 · Cited by 273 · see citing works
High‐molecular‐weight β‐amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
Fukumoto, H., Tokuda, T., Kasai, T., Ishigami, N., Hidaka, H., Kondo, M., Allsop, D., & Nakagawa, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-150359 · Cited by 264 · see citing works
Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition
Lim, C. Z. J., Zhang, Y., Chen, Y., Zhao, H., Stephenson, M. C., Ho, N. R. Y., Chen, Y., Chung, J., Reilhac, A., Loh, T. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09030-2 · Cited by 209 · see citing works
Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease
Salvadores, N., Shahnawaz, M., Scarpini, E. A., Tagliavini, F., & Soto, C. A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.031 · Cited by 200 · see citing works
Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer’s Disease?
Doig, A. J., del Castillo‐Frias, M. P., Berthoumieu, O., Tarus, B., Nasica-Labouze, J., Sterpone, F., Nguyen, P. H., Hooper, N. M., Faller, P., & Derreumaux, P. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00188 · Cited by 198 · see citing works
CSF biomarkers cutoffs: The importance of coincident neuropathological diseases
Toledo, J. B., Brettschneider, J., Grossman, M., Arnold, S. E., Hu, W. T., Xie, S. X., Lee, V. M.-Y., Shaw, L. M., & Trojanowski, J. Q. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0983-7 · Cited by 182 · see citing works
Developing novel blood‐based biomarkers for Alzheimer's disease
Snyder, H. M., Carrillo, M. C., Grodstein, F., Henriksen, K., Jeromin, A., Lovestone, S., Mielke, M. M., O'Bryant, S., Sarasa, M., Sj⊘gren, M., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.10.007 · Cited by 177 · see citing works
Zhong, S., Zhuang, J., Yang, D., & Tang, D. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.04.038 · Cited by 174 · see citing works
Mahmoudi, M., Quinlan-Pluck, F., Monopoli, M. P., Sheibani, S., Vali, H., Dawson, K. A., & Lynch, I. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300196n · Cited by 159 · see citing works
Xiong, N., Dong, X., Zheng, J., Liu, F., & Sun, Y. P. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b00915 · Cited by 158 · see citing works
Cedazo-Mı́nguez, Á., & Winblad, B. G. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.09.008 · Cited by 156 · see citing works
Demeritte, T., Nellore, B. P. V., Kanchanapally, R., Sinha, S. S., Pramanik, A., Chavva, S. R., & Ray, P. C. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b03619 · Cited by 154 · see citing works
Xia, N., Wang, X., Zhou, B., Wu, Y., Mao, W., & Liu, L. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b05423 · Cited by 144 · see citing works
Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
Toledo, J. B., Shaw, L. M. J., & Trojanowski, J. Q. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt162 · Cited by 135 · see citing works
Amyloid-β detection with saccharide immobilized gold nanoparticle on carbon electrode
Chikae, M., Fukuda, T., Kerman, K., Idegami, K., Miura, Y., & Tamiya, E. (2008) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2008.06.005 · Cited by 132 · see citing works
Yang, T., Hong, S. Y., O’Malley, T. T., Sperling, R. A., Walsh, D. M., & Selkoe, D. J. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.11.005 · Cited by 121 · see citing works
Amyloid β and APP as biomarkers for Alzheimer’s disease
Zetterberg, H., Blennow, K., & Hanse, E. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.08.002 · Cited by 113 · see citing works
Role of aromatic side chains in amyloid β-protein aggregation.
Cukalevski, R., Boland, B., Frohm, B., Thulin, E., Walsh, D., & Linse, S. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300073s · Cited by 108 · see citing works
He, X., Deng, Q., Cai, L., Wang, C.-Z., Zang, Y., Li, J. X., Chen, G., & Tian, H. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am5010909 · Cited by 84 · see citing works
Hahn, S., Kim, S.-S., Lee, C., et al. (2005) · The Journal of Chemical Physics · doi:10.1063/1.1997151 · Cited by 81 · see citing works
Self-assembled fluorescent tripeptide nanoparticles for bioimaging and drug delivery applications
Fu, D., Liu, D., Zhang, L., & Sun, L. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.07.011 · Cited by 79 · see citing works
Self-citationJancy, B., & Asha, S. K. (2007) · Chemistry of Materials · doi:10.1021/cm702497y · Cited by 76 · see citing works
Real-Time Imaging and Quantification of Amyloid-β Peptide Aggregates by Novel Quantum-Dot Nanoprobes
Tokuraku, K., Marquardt, M., & Ikezu, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008492 · Cited by 75 · see citing works
Brettschneider, S., Morgenthaler, N. G., Teipel, S. J., Fischer-Schulz, C., Bürger, K., Dodel, R. C., Du, Y., Möller, H., Bergmann, A., & Hampel, H. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.008 · Cited by 70 · see citing works
Tunable synthesis of self-assembled cyclic peptide nanotubes and nanoparticles
Sun, L., Fan, Z., Wang, Y., Huang, Y., Schmidt, M., & Zhang, M. (2015) · Soft Matter · doi:10.1039/c5sm00533g · Cited by 69 · see citing works
Self-citationYang, D., Guo, W., Cai, Z., et al. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.01.096 · Cited by 69 · see citing works
Neuropathological investigation of dementia: a guide for neurologists
Love, S. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.080754 · Cited by 67 · see citing works
Tabersonine Inhibits Amyloid Fibril Formation and Cytotoxicity of Aβ(1–42)
Kai, T., Zhang, L., Wang, X., Jing, A., Zhao, B., Yu, X., Zheng, J., & Zhou, F. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00015 · Cited by 65 · see citing works
Self-citationPlasma amyloid-β oligomers level is a biomarker for Alzheimer’s disease diagnosis
Zhou, L., Chan, K. H., Chu, L., Kwan, J., Song, Y., Chen, L. H., Ho, P. W., Cheng, O., Ho, J. W.-M., & Lam, K. S. L. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.017 · Cited by 57 · see citing works
Self‐Assembled Fluorescent and Antibacterial GHK‐Cu Nanoparticles for Wound Healing Applications
Sun, L., Li, A., Hu, Y., Li, Y., Shang, L., & Zhang, L. (2019) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201800420 · Cited by 47 · see citing works
Self-citationBlasko, I., Kemmler, G., Krampla, W. W., Jungwirth, S., Wichart, I., Jellinger, K. A., Tragl, K. H., & Fischer, P. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.006 · Cited by 46 · see citing works
Lysosomal Fusion Dysfunction as a Unifying Hypothesis for Alzheimer's Disease Pathology
Funk, K. E., & Kuret, J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/752894 · Cited by 41 · see citing works
Kundu, A., Hariharan, P. S., Prabakaran, K., et al. (2016) · Crystal Growth & Design · doi:10.1021/acs.cgd.6b00396 · Cited by 37 · see citing works
Misfolding of Amyloidogenic Proteins and Their Interactions with Membranes
Relini, A., Marano, N., & Gliozzi, A. (2013) · Biomolecules · doi:10.3390/biom4010020 · Cited by 34 · see citing works
KLVFF peptide functionalized nanoparticles capture Aβ42 by co-assembly for decreasing cytotoxicity
Yang, P., Yang, C., Zhang, K., Wang, L., & Wang, H. (2018) · Chinese Chemical Letters · doi:10.1016/j.cclet.2018.10.003 · Cited by 29 · see citing works
Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples
Kasai, T., Tokuda, T., Taylor, M., Kondo, M., Mann, D. M. A., Foulds, P. G., Nakagawa, M., & Allsop, D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.029 · Cited by 26 · see citing works
Liu, Y., Zheng, Y., Li, S., et al. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.04.052 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works
Self-citationBlood-based Alzheimer's disease diagnosis using fluorescent peptide nanoparticle arrays
Sun, L., Lei, Y., Wang, Y., & Liu, D. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.10.071 · Cited by 18 · see citing works
Self-citation
- Authors
- Sun, L., Liu, D., Fu, D., Yue, T., Scharre, D., & Zhang, L.
- Affiliations
- Northwestern Polytechnical University (CN)
- Shanghai University (CN)
- The Ohio State University Wexner Medical Center (US)
- Corresponding author
- Sun, Leming
- Zhang, Lianbing
- Venue
- Chemical Engineering Journal
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 405
- Pages
- 126733
- ISSN
- 1385-8947 (ISSN-L)
- OpenAlex
- W3081178396
- Cited by
- 32
- References
- 55
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 9 · 2023: 6 · 2022: 4 · 2021: 5
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Chemical Engineering Journal (publishedVersion)
- Funders
- National Natural Science Foundation of China (31900984, 31971315)
- China Postdoctoral Science Foundation (2018M631197)
- Natural Science Foundation of Shaanxi Province (2019JQ-231)
- Shaanxi Province Postdoctoral Science Foundation (2018BSHQYXMZZ42)
- Fundamental Research Funds for the Central Universities (31020180QD063)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Physical Sciences › Chemistry › Spectroscopy › Molecular Sensors and Ion Detection
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta aggregation, cerebrospinal fluid, serum biomarkers, disease diagnosis, disease progression monitoring, electrostatic interactions, non-invasive diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
